Latest Insider Transactions at Lucira Health, Inc. (LHDX)
This section provides a real-time view of insider transactions for Lucira Health, Inc. (LHDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lucira Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lucira Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 07
2023
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
81,717
-25.81%
|
$0
$0.48 P/Share
|
Mar 07
2023
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,382
-2.97%
|
$0
$0.45 P/Share
|
Mar 06
2023
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,910
-2.32%
|
$0
$0.57 P/Share
|
Mar 03
2023
|
Erik T. Engelson President and Chief Executive |
SELL
Open market or private sale
|
Direct |
634,666
-79.69%
|
$634,666
$1.06 P/Share
|
Mar 03
2023
|
Erik T. Engelson President and Chief Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
574,666
+46.62%
|
$0
$0.82 P/Share
|
Mar 03
2023
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
30,102
-8.68%
|
$30,102
$1.15 P/Share
|
Mar 03
2023
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,091
-8.47%
|
$25,091
$1.07 P/Share
|
Mar 03
2023
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
8,405
-5.8%
|
$8,405
$1.0 P/Share
|
Feb 16
2023
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
5,028
-3.61%
|
$0
$0.27 P/Share
|
Dec 20
2022
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
4,263
-2.86%
|
$0
$0.16 P/Share
|
Dec 14
2022
|
Epiq Capital Group, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
982,417
+44.38%
|
-
|
Dec 14
2022
|
Epiq Capital Group, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
13,124,349
-61.98%
|
-
|
Dec 01
2022
|
Richard Clavano Narido Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,583
-1.45%
|
$0
$0.36 P/Share
|
Nov 28
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
7,537
-5.14%
|
$0
$0.42 P/Share
|
Nov 27
2022
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
9,666
-2.71%
|
$0
$0.42 P/Share
|
Nov 21
2022
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
34,429
-9.54%
|
$0
$0.33 P/Share
|
Nov 17
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
33,247
-9.57%
|
$0
$0.38 P/Share
|
Nov 16
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
4,790
-2.59%
|
$0
$0.35 P/Share
|
Sep 20
2022
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
17,052
-8.5%
|
$17,052
$1.39 P/Share
|
Sep 18
2022
|
Dan George CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
343
-0.74%
|
$343
$1.38 P/Share
|
Sep 15
2022
|
Erik T. Engelson President and Chief Executive |
BUY
Open market or private purchase
|
Direct |
20,000
+19.36%
|
$20,000
$1.82 P/Share
|
Sep 01
2022
|
Debkishore Mitra Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
191
-0.05%
|
$191
$1.69 P/Share
|
Aug 27
2022
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
8,580
-2.35%
|
$8,580
$1.72 P/Share
|
Aug 25
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
1,500
-0.81%
|
$1,500
$1.93 P/Share
|
Aug 18
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
3,500
-1.94%
|
$7,000
$2.25 P/Share
|
Aug 17
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
19,074
-9.55%
|
$38,148
$2.83 P/Share
|
Jul 08
2022
|
Tamanna Prashar Vice President |
SELL
Open market or private sale
|
Direct |
248
-0.21%
|
$496
$2.52 P/Share
|
Jun 18
2022
|
Dan George CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,321
-2.77%
|
$1,321
$1.45 P/Share
|
Jun 16
2022
|
Erik T. Engelson President and Chief Executive |
BUY
Open market or private purchase
|
Direct |
10,000
+13.65%
|
$10,000
$1.49 P/Share
|
Jun 01
2022
|
Debkishore Mitra Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
186
-0.05%
|
$186
$1.85 P/Share
|
Jun 01
2022
|
Tamanna Prashar Vice President |
SELL
Open market or private sale
|
Direct |
257
-0.22%
|
$257
$1.85 P/Share
|
May 27
2022
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
37,109
-9.23%
|
$74,218
$2.0 P/Share
|
Mar 15
2022
|
Erik T. Engelson President and Chief Executive |
BUY
Open market or private purchase
|
Direct |
30,000
+36.02%
|
$90,000
$3.0 P/Share
|
Mar 01
2022
|
Debkishore Mitra Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
890
-0.23%
|
$3,560
$4.68 P/Share
|
Mar 01
2022
|
Tamanna Prashar Vice President |
SELL
Open market or private sale
|
Direct |
1,289
-1.08%
|
$5,156
$4.68 P/Share
|
Sep 30
2021
|
Anthony Joseph Allen Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
197,240
+50.0%
|
-
|
Sep 30
2021
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
197,240
+50.0%
|
-
|
Jun 18
2021
|
Dan George CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.57%
|
-
|
Jun 18
2021
|
Hansgregory C. Hartmann Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+23.08%
|
-
|
Jun 09
2021
|
Tamanna Prashar Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
103,691
+16.82%
|
$103,691
$1.12 P/Share
|
Mar 10
2021
|
Brezoczky Kelly Lewis Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+24.6%
|
-
|
Mar 10
2021
|
Hansgregory C. Hartmann Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+50.0%
|
-
|
Mar 10
2021
|
Debkishore Mitra Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,250
+2.13%
|
-
|
Mar 10
2021
|
Tamanna Prashar Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,475
+50.0%
|
-
|
Feb 09
2021
|
Erik T. Engelson President and Chief Executive |
BUY
Conversion of derivative security
|
Direct |
23,282
+50.0%
|
-
|
Feb 09
2021
|
Dan George CFO and Treasurer |
BUY
Conversion of derivative security
|
Direct |
24,013
+36.4%
|
-
|
Feb 09
2021
|
David Lamond Director |
BUY
Conversion of derivative security
|
Indirect |
146,385
+44.39%
|
-
|
Feb 09
2021
|
Brezoczky Kelly Lewis Executive Vice President |
BUY
Conversion of derivative security
|
Direct |
23,231
+50.0%
|
-
|
Feb 09
2021
|
Lior Susan Director |
BUY
Conversion of derivative security
|
Indirect |
6,223,795
+30.13%
|
$80,909,335
$13.6 P/Share
|
Feb 09
2021
|
Eclipse Gp Iii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,183,986
+30.09%
|
$54,391,818
$13.6 P/Share
|